We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+2.2%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.12B
AUM Growth
-$54.3M
Cap. Flow
+$518K
Cap. Flow %
0.01%
Top 10 Hldgs %
6.44%
Holding
1,475
New
99
Increased
592
Reduced
300
Closed
114

Sector Composition

Rank Sector Weight
1 Financials 25.32%
2 Consumer Discretionary 11.88%
3 Industrials 11.76%
4 Technology 10.68%
5 Energy 10.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REAL icon
851
The RealReal
REAL
$1.5B
$546K 0.01%
259,000
+38,500
+17% +$93.9K
CPIX icon
852
Cumberland Pharmaceuticals
CPIX
$117M
$542K 0.01%
286,655
BIG
853
DELISTED
Big Lots, Inc.
BIG
$538K 0.01%
105,300
-442,299
-81% -$3.36M
KEQU icon
854
Kewaunee Scientific
KEQU
$106M
$538K 0.01%
30,400
PDLB icon
855
Ponce Financial Group
PDLB
$485M
$538K 0.01%
68,761
+1,106
+2% +$9.48K
AMSC icon
856
American Superconductor
AMSC
$1.59B
$538K 0.01%
71,200
-20,000
-22% -$166K
ASYS icon
857
Amtech Systems
ASYS
$272M
$530K 0.01%
69,600
LMB icon
858
Limbach Holdings
LMB
$581M
$529K 0.01%
16,675
+474
+3% +$14.3K
BWB icon
859
Bridgewater Bancshares
BWB
$603M
$527K 0.01%
55,639
+632
+1% +$6.51K
GNTY
860
DELISTED
Guaranty Bancshares
GNTY
$526K 0.01%
18,330
+1,422
+8% +$41.9K
APYX icon
861
Apyx Medical
APYX
$171M
$522K 0.01%
163,100
YMAB
862
DELISTED
Y-mAbs Therapeutics
YMAB
$521K 0.01%
95,600
+20,600
+27% +$120K
TRT
863
Trio-Tech International
TRT
$113M
$520K 0.01%
148,450
+4,108
+3% +$12.5K
RELL icon
864
Richardson Electronics
RELL
$304M
$516K 0.01%
47,211
-1,795
-4% -$23.1K
TG icon
865
Tredegar Corp
TG
$310M
$511K 0.01%
+94,500
New +$551K
MASS icon
866
908 Devices
MASS
$364M
$508K 0.01%
+76,300
New +$528K
CTV
867
DELISTED
Innovid Corp.
CTV
$506K 0.01%
395,200
+45,200
+13% +$52.9K
SKIL icon
868
Skillsoft
SKIL
$81.6M
$505K 0.01%
+28,500
New +$722K
CRMD icon
869
CorMedix
CRMD
$584M
$502K 0.01%
135,700
+50,500
+59% +$201K
NTB icon
870
Bank of N.T. Butterfield & Son
NTB
$2.45B
$502K 0.01%
18,525
-45,078
-71% -$1.31M
IMA
871
ImageneBio Inc
IMA
$64.6M
$496K 0.01%
9,554
PBPB
872
DELISTED
Potbelly
PBPB
$496K 0.01%
63,600
-50,000
-44% -$426K
TSHA icon
873
Taysha Gene Therapies
TSHA
$1.89B
$494K 0.01%
156,300
GENC icon
874
Gencor Industries
GENC
$212M
$490K 0.01%
34,650
+3,500
+11% +$51.4K
GAN
875
DELISTED
GAN Ltd
GAN
$489K 0.01%
421,279

Similar funds

Bridgeway Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Bridgeway Capital Management held 1,475 positions worth $4.12B, down 1.3% from $4.18B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.

Bridgeway Capital Management's Q3 2023 filing shows 99 new, 592 increased, 300 reduced and 114 closed positions. Its largest new stake was Vir Biotechnology: 1,345,635 shares worth $12.6M. The largest sale was Boise Cascade, an estimated $17.7M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q3 2023 buy was Vir Biotechnology: 1,345,635 shares worth $12.6M.
  • Bridgeway Capital Management added most to Oracle in Q3 2023, an estimated $12.4M increase.
  • Bridgeway Capital Management's biggest Q3 2023 reduction was Boise Cascade, cutting an estimated $17.7M.
  • Bridgeway Capital Management fully exited Treehouse Foods in Q3 2023, selling an estimated $11.5M.
  • Bridgeway Capital Management's ten largest holdings make up 6.4% of its $4.12B portfolio in Q3 2023.
  • Bridgeway Capital Management opened 99 new positions and closed 114 in Q3 2023.
  • Bridgeway Capital Management's portfolio value fell 1.3% quarter-over-quarter to $4.12B.

Based on Bridgeway Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.